Inventor
VAGNER JOSEF
DK17 patents
⚠️ This page may combine multiple inventors who share the name “VAGNER JOSEF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
H LEE MOFFITT CANCER CT & RES
7 patentsUS10793595B2Oct 6, 2020
Toll-like receptor 2 ligands and methods of making and using thereof
H LEE MOFFITT CANCER CT & RES2 citations70
US10118942B2Nov 6, 2018
Toll-like receptor 2 ligands and methods of making and using thereof
H LEE MOFFITT CANCER CT & RES4 citations70
US11458212B2Oct 4, 2022
Molecular imaging of cancer cells in vivo
H LEE MOFFITT CANCER CT & RES0 citations61
US12173087B2Dec 24, 2024
Melanocortin 1 receptor ligands and methods of use
H LEE MOFFITT CANCER CT & RES0 citations60
US11414455B2Aug 16, 2022
Toll-like receptor 2 ligands and methods of making and using thereof
H LEE MOFFITT CANCER CT & RES0 citations60
US11230568B2Jan 25, 2022
Melanocortin 1 receptor ligands and methods of use
H LEE MOFFITT CANCER CT & RES0 citations60
US10329326B2Jun 25, 2019
Melanocortin 1 receptor ligands and methods of use
H LEE MOFFITT CANCER CT & RES0 citations50
UNIV ARIZONA
4 patentsUS10308656B2Jun 4, 2019
Small molecule inhibitors of Ku70/80 and uses thereof
UNIV ARIZONA1 citations56
US11306130B2Apr 19, 2022
PAR3 mimetic peptides and uses thereof
UNIV ARIZONA0 citations53
US11952379B2Apr 9, 2024
Small molecule modulators of PAR2 and uses thereof
UNIV ARIZONA0 citations45
US11351264B2Jun 7, 2022
PAR2 mimetic peptides and uses thereof
UNIV ARIZONA0 citations45